These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

709 related items for PubMed ID: 12036948

  • 1. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
    Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR.
    Cancer Res; 2002 Jun 01; 62(11):3298-307. PubMed ID: 12036948
    [Abstract] [Full Text] [Related]

  • 2. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ, Ressler SJ, Larsen M, Tuxhorn JA, Yang F, Dang TD, Rowley DR.
    Cancer Res; 2003 Sep 15; 63(18):5859-65. PubMed ID: 14522910
    [Abstract] [Full Text] [Related]

  • 3. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F, Strand DW, Rowley DR.
    Oncogene; 2008 Jan 17; 27(4):450-9. PubMed ID: 17637743
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model.
    Tuxhorn JA, McAlhany SJ, Yang F, Dang TD, Rowley DR.
    Cancer Res; 2002 Nov 01; 62(21):6021-5. PubMed ID: 12414622
    [Abstract] [Full Text] [Related]

  • 5. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA, Harb JF, Barroso U, He Z, Grignon DJ, Cher ML.
    Cancer Res; 1999 Apr 15; 59(8):1987-93. PubMed ID: 10213511
    [Abstract] [Full Text] [Related]

  • 6. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL, Gardner TA, Miao L, Balian G, Chung LW.
    Cancer Gene Ther; 2004 Feb 15; 11(2):148-55. PubMed ID: 14695756
    [Abstract] [Full Text] [Related]

  • 7. Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors.
    Gleave ME, Hsieh JT, Wu HC, von Eschenbach AC, Chung LW.
    Cancer Res; 1992 Mar 15; 52(6):1598-605. PubMed ID: 1371718
    [Abstract] [Full Text] [Related]

  • 8. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T, Lin FF, Rao P, Lin MF.
    Prostate; 2003 Jun 01; 55(4):247-58. PubMed ID: 12712404
    [Abstract] [Full Text] [Related]

  • 9. The effect of fibroblast growth factor 8, isoform b, on the biology of prostate carcinoma cells and their interaction with stromal cells.
    Song Z, Powell WC, Kasahara N, van Bokhoven A, Miller GJ, Roy-Burman P.
    Cancer Res; 2000 Dec 01; 60(23):6730-6. PubMed ID: 11118059
    [Abstract] [Full Text] [Related]

  • 10. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells.
    Mueller MM, Fusenig NE.
    Differentiation; 2002 Dec 01; 70(9-10):486-97. PubMed ID: 12492491
    [Abstract] [Full Text] [Related]

  • 11. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P, Karashima T, Kim SJ, Kedar D, Mian B, Huang S, Baker C, Fan Z, Hicklin DJ, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2002 Aug 01; 8(8):2714-24. PubMed ID: 12171905
    [Abstract] [Full Text] [Related]

  • 12. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
    Jin RJ, Wang Y, Masumori N, Ishii K, Tsukamoto T, Shappell SB, Hayward SW, Kasper S, Matusik RJ.
    Cancer Res; 2004 Aug 01; 64(15):5489-95. PubMed ID: 15289359
    [Abstract] [Full Text] [Related]

  • 13. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A, Xiao N, Kang J, Best CJ, Leiva I, Emmert-Buck MR, Jorcyk C, Green JE.
    Cancer Res; 2002 Sep 15; 62(18):5325-35. PubMed ID: 12235003
    [Abstract] [Full Text] [Related]

  • 14. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts.
    Gleave M, Hsieh JT, Gao CA, von Eschenbach AC, Chung LW.
    Cancer Res; 1991 Jul 15; 51(14):3753-61. PubMed ID: 1712249
    [Abstract] [Full Text] [Related]

  • 15. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO, Yeon Chun J, Nadiminty N, Trump DL, Ip C, Dong Y, Gao AC.
    Prostate; 2006 Jul 01; 66(10):1070-5. PubMed ID: 16637076
    [Abstract] [Full Text] [Related]

  • 16. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo.
    Srivastava SK, Xiao D, Lew KL, Hershberger P, Kokkinakis DM, Johnson CS, Trump DL, Singh SV.
    Carcinogenesis; 2003 Oct 01; 24(10):1665-70. PubMed ID: 12896904
    [Abstract] [Full Text] [Related]

  • 17. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.
    Sato N, Gleave ME, Bruchovsky N, Rennie PS, Beraldi E, Sullivan LD.
    Cancer Res; 1997 Apr 15; 57(8):1584-9. PubMed ID: 9108464
    [Abstract] [Full Text] [Related]

  • 18. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
    Levine L, Lucci JA, Pazdrak B, Cheng JZ, Guo YS, Townsend CM, Hellmich MR.
    Cancer Res; 2003 Jul 01; 63(13):3495-502. PubMed ID: 12839933
    [Abstract] [Full Text] [Related]

  • 19. Vasoactive intestinal peptide enhances growth and angiogenesis of human experimental prostate cancer in a xenograft model.
    Collado B, Carmena MJ, Clemente C, Prieto JC, Bajo AM.
    Peptides; 2007 Sep 01; 28(9):1896-901. PubMed ID: 17544169
    [Abstract] [Full Text] [Related]

  • 20. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
    Wu GJ, Peng Q, Fu P, Wang SW, Chiang CF, Dillehay DL, Wu MW.
    Gene; 2004 Mar 03; 327(2):201-13. PubMed ID: 14980717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.